Expression patterns of microRNAs associated with CML phases and their disease related targets

Molecular Cancer

Volumn 10, Issue , 2011, Pages

  Machová Polaková, Kateřina ^a   Lopotová, Tereza ^a,b   Klamová, Hana ^a   Burda, Pavel ^b   Trněný, Marek ^a   Stopka, Tomáš ^b   Moravcová, Jana ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; IMATINIB; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA1; MIRN150 MICRORNA, HUMAN;

ARTICLE; BLAST CELL CRISIS; CANCER STAGING; CELL CYCLE; CELL CYCLE REGULATION; CELL GROWTH; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE TARGETING; HEMATOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA RELAPSE; MALE; MICROARRAY ANALYSIS; PATHOGENESIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT FAILURE; CLUSTER ANALYSIS; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; ONCOGENE MYB; PATHOPHYSIOLOGY; REPRODUCIBILITY;

CLUSTER ANALYSIS; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GENES, MYB; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MICRORNAS; MOLECULAR SEQUENCE ANNOTATION; REPRODUCIBILITY OF RESULTS;

EID: 79955081574     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-10-41     Document Type: Article

References (46)

1. Boutla A, Delidakis C, Tabler M. Developmental defects by antisense-mediated inactivation of micro-RNAs 2 and 13 in Drosophila and the identification of putative target genes. Nuc Ac Res 2003, 31:4973-4980.
2. Barbee SA, Estes PS, Cziko AM, Hillebrantd J, Luedeman RA, Coller JM, Johnson N, Howlett IC, Ceng C, Ueda R, Brand AH, Newbury SF, Wilhelm JE, Levine RB, Nakamura A, Parker R, Ramaswami M. Staufen- and FMRP containing neuronal RNPs are structurally and functionally related to somatic P bodies. Neuron 2006, 52:997-1009. 10.1016/j.neuron.2006.10.028, 1955741, 17178403.
3. Bhattacharyya SN, Habermacher R, Martine U, Closs EI, Filipowicz. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 2006, 125:1111-1124. 10.1016/j.cell.2006.04.031, 16777601.
4. Carthew RW. RNA interference: the fragile X syndrome connection. Curr Biol 2002, 12:R852-854. 10.1016/S0960-9822(02)01352-0, 12498706.
5. Epanchinstev A, Jung P, Menssen A, Hermeking H. Inducible microRNA expression by an all-in-one episomal vector system. Nuc Ac Res 34:e119.
6. Calin GA, Calin DD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. PNAS 2002, 26:15524-15529.
7. Calin GA, Liu CG, Svignani C, Ferracin M, Felli N, Dumitru CD, Shimizu M, Cimmino A, Zupo S, Dono M, Dell' Aquilla ML, Alder H, Rassenti L, Kipps TJ, Bullrich F, Negrini M, Groce CM. MicroRNA profiling reverses distinct signatures in B cell chronic lymphocytic leukemias. PNAS 2004, 101:11755-11760. 10.1073/pnas.0404432101, 511048, 15284443.
8. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, Liang S, Naylor TL, Barchetti A, Ward MR, Yao G, Medina A, O'Brien-Jenkins A, Katsaros D, Hatzigeorgiou A, Gimotty PA, Weber BL, Coukos G. Micro-RNAs exhibit high frequency genomic alterations in human cancer. PNAS 2006, 103:9136-9141. 10.1073/pnas.0508889103, 1474008, 16754881.
9. Bueno MJ, de Castro IP, de Cedrón MG, Santos J, Calin GA, Cigudosa JC, Croce CM, Piqueras JF, Malumbres M. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 2008, 13:496-506. 10.1016/j.ccr.2008.04.018, 18538733.
10. Albano F, Anelli L, Zagaria A, Liso V, Rocchi M, Specchia G. MIRN199B downregulation in chronic myeloid leukaemia is associated with deletions on der(9). BJ of Haematology 2009, 144:271-273.
11. Venturini L, Battmer K, Castoldi M, Schultheis B, Hochhaus A, Muckenthaler MU, Ganser A, Eder M, Scherr M. Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood 2007, 109:4399-405. 10.1182/blood-2006-09-045104, 17284533.
12. Agirre X, Velasco A, San José-Enériz E, Garate L, Bandrés E, Cordeu L, Aparicio O, Saez B, Navarro G, Vilas-Zornoza A, Pérez-Roger I, García-Foncillas J, Torres A, Heiniger A, Calasanz MJ, Fortes P, Román-Gómez J, Prósper F. Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. Mol Cancer Res 2008, 6:1830-1840. 10.1158/1541-7786.MCR-08-0167, 19074828.
13. Enériz ESJ, Román-Gómez J, Jiménez-Velasco A, Garate L, Maritn V, Coredu L, Vilas-Zornoza A, Rodríguez-Otero P, Calasanz MJ, Pr'ésper F, Agirre X. MicroRNA expression profiling in imatinib-resistant chronic myeloid leukemia patients without clinically significant ABLI-mutations. Mol Cancer 2009, 8:69-72. 10.1186/1476-4598-8-69, 2743636, 19723306.
14. Flamant S, Richie W, Guilhot J, Hols J, Bonnet ML, Chomel JC, Guilhot F, Turhan AG, Rasko JEJ. Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia. Haematologica 2010, 95:1325-1333. 10.3324/haematol.2009.020636, 2913081, 20460641.
15. Poláková KM, Lopotová T, Klamová H, Moravcová J. Differential expression of miRNAs during the course of chronic myeloid leukemia. Blood 2008, 112:s1082.
16. Barroga CF, Pham H, Kaushansky K. Thrombopoietin regulates c-Myb expression by modulating micro RNA miR-150 and high BIC/miR-155 expression. Exp Hematol 2008, 36:1585-1592. 10.1016/j.exphem.2008.07.001, 2600728, 18814950.
17. Rulcová J, Zmeková V, Zemanová Z, Klamová H, Moravcová J. The effect of total-ABL, GUS and B2M control genes on BCR-ABL monitoring by real-time RT-PCR. Leuk Res 2007, 31:483-491. 10.1016/j.leukres.2006.07.021, 16945414.
18. Polaková KM, Lopotová T, Klamová H, Moravcová J. High-resolution melt curve analysis: Initial screening for mutations in BCR-ABL kinase domain. Leuk Res 2008, 32:1236-1243. 10.1016/j.leukres.2008.01.010, 18308387.
19. Kendziorski C, Irizarry RA, Chen KS, Haag JD, Gould MN. On the utility of pooling biological samples in microarray experiments. PNAS 2005, 102:4252-4257. 10.1073/pnas.0500607102, 552978, 15755808.
20. Peng X, Wood CL, Blalock EM, Chen K, Landfield PW, Stromberg AJ. Statistical implications of pooling RNA samples for microarray experiments. BMC Bioinf 2003, 4:26-35.
21. Beillard E, Pallisgaard N, van der Velden VH, Bi W, Dee R, van der Schoot E, Delabesse E, Macintyre E, Gottardi E, Saglio G, Watzinger F, Lion T, van Dongen JJ, Hokland P, Gabert J. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program. Leukemia 2003, 17:2474-2486. 10.1038/sj.leu.2403136, 14562124.
22. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nature Protocol 2009, 4:44-57.
23. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4:P3. 10.1186/gb-2003-4-5-p3, 12734009.
24. Friedman RC, Farh KKH, Burge C, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009, 19:92-105. 10.1101/gr.082701.108, 2612969, 18955434.
25. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 2010, 38:D355-D360. 10.1093/nar/gkp896, 2808910, 19880382.
26. Chen C, Li, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303:83-86. 10.1126/science.1091903, 14657504.
27. Eisendle K, Lang A, Eibl B, Nachbaur D, Glassl H, Fiegl M, Thaler J, Gastl G. Phenotypic and functional deficiencies of leukaemic dendritic cells from patients with chronic myeloid leukaemia. BJ of Haematology 2003, 120:63-73.
28. Carayol N, Vakana E, Sassano A, Kaur S, Goussetis DJ, Glaser H, Druker BJ, Donato JN, Altman JK, Barr S, Platanias LC. Critical roles for mTORC2- and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cells. PNAS 2010, 107:12469-12474. 10.1073/pnas.1005114107, 2906574, 20616057.
29. Mayerhofer M, Aichleberger KJ, Florian S, Krauth MT, Hauswirth AW, Derdak S, Sperr WR, Esterbauer H, Wagner O, Marosi C, Pickl WF, Deininger M, Weisberg E, Druker BJ, Griffin JD, Sillaber C, Valent P. Identification of mTOR as a novel bifunctional target in chronic myeloid leukemia: dissection of growth-inhibitory and VEGF-suppressive effects of rapamycin in leukemic cells. FASEB 2005, 19:960-962.
30. Zhao C, Chen A, Jamieson CH, Fereshteh M, Abrahamsson A, Blum J, Kwon HY, Chute JP, Rizzieri D, Munchhof M, VanArsdale T, Beachy PA, Reya T. Hedgehog signaling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 2009, 458:776-779. 10.1038/nature07737, 2946231, 19169242.
31. Dierks C, Beigi R, Guo GR, Zirlik K, Stegert MR, Manley P, Trussell C, Shcmitt-Graeff A, Landwerlin K, Veelken H, Warmuth M. Expansion of Bcr-Abl-positive leukemic stem cells is dependent of Hedgehog pathway activation. Cancer Cell 2008, 14:238-249. 10.1016/j.ccr.2008.08.003, 18772113.
32. Brunton VG, Avizienyte E, Fincham VJ, Serrels B, Metcalf C, Saqyer TK, Frame MC. Identification of Src-specific phosphorylation site on focal adhesion kinase: dissection of the role of Src SH2 and catalytic function and their consequences for tumor cell behavior. Cancer Res 2005, 65:1335-1342. 10.1158/0008-5472.CAN-04-1949, 15735019.
33. Salgia R, Brunkhorst B, Pisick E, Li JL, Lo SH, Chen LB, Griffin JD. Increased tyrosine phosphorylation of focal adhesion proteins in myeloid cell lines expressing p210BCR/ABL. Oncogene 1995, 11:1149-1155.
34. Desphande AJ, Buske C. Knocking the Wnt out of the sails of leukemia stem cell development. Cell Stem Cell 2007, 1:597-598. 10.1016/j.stem.2007.11.006, 18371398.
35. Ress A, Moelling K. Bcr is a negative regulator of the Wnt signalling pathway. EMBO 2005, 6:1095-1100.
36. Kang C, Yoo SD, Hwanga BW, Kima KW, Kimc DW, Kima C, Kima SH, Chunga BS. The inhibition of ERK/MAPK not the activation of JNK/SAPK is primarily required to induce apoptosis in chronic myelogenous leukemic K562 cells. Leuk Res 2000, 24:527-534. 10.1016/S0145-2126(00)00010-2, 10781688.
37. Chu S, Holtz M, Gupta M, Bhatia R. BCR/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells. Blood 2004, 103:3167-3174. 10.1182/blood-2003-04-1271, 15070699.
38. Burchert A, Wang Y, Cai D, von Bubnoff N, Paschka P, Mueller-Bruesselbach S, Ottmann OG, Duyster J, Hochhasou A, Neubauer A. Compensatory PI3-kinase/Akt/mTor activation regulates resistance development. Leukemia 2005, 19:1774-1782. 10.1038/sj.leu.2403898, 16136169.
39. Bruchova H, Yoon D, Agarwal AM, Mendell J, Prchal JT. Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis. Exp Hematol 2007, 35:1657-1667. 10.1016/j.exphem.2007.08.021, 2699372, 17976518.
40. Zhou B, Wang S, Mayer C, Bartel DP, Lodish HF. MiR-150, a micro RNA expressed in mature B and T cells, blocs early B cell development when expressed prematurely. Proc Natl Acad Sci 2007, 104:1080-7085.
41. Xiao C, Calado DP, Galler G, Thai TH, Patterson H, Wang J, Rajewsky N, Bender TP, Rajewsky K. MiR-150 controls B-cell differentiation by targeting the transcription factor c-Myb. Cell 2007, 131:146-159. 10.1016/j.cell.2007.07.021, 17923094.
42. Lu J, Guo S, Ebert BL, Zhang H, Peng Y, Bosco J, Pretz J, Schlanger R, Wang YJ, Mak RH, Dombkowski DM, Preffer FI, Scadden DT, Golub TR. MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Developmental Cell 2008, 14:843-853. 10.1016/j.devcel.2008.03.012, 2688789, 18539114.
43. Bruchova H, Yoon D, Agarwal AM, Swierczek S, Prchal JT. Erythropoiesis in polycythemia vera is hyper-proliferative and has accelerated maturation. Blood Cells, Molecules, and Diseases 2009, 43:81-87. 10.1016/j.bcmd.2009.02.001, 2693444, 19264517.
44. Hussein K, Theophile K, Busche G, Schlegelberger B, Gohring G, Kreipe H, Bock O. Significant inverse correlation of microRNA-150/MYB and microRNA-222/p27 in myelodysplastic syndrome. Leuk Res 2010, 34:328-334. 10.1016/j.leukres.2009.06.014, 19615744.
45. Fulci V, Chiaretti S, Goldoni M, Azzalin G, Carucci N, Tavolaro S, Castellano L, Magrelli A, Citarella F, Messina M, Maggio R, Peragine N, Santangelo S, Mauro FR, Landgraf P, Tuschl T, Weir DB, Chien M, Russo JJ, Ju J, Sheridan R, Sander C, Zavolan M, Guarini A, Foa R, Macino G. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 2007, 109:4944-4951. 10.1182/blood-2006-12-062398, 17327404.
46. Lidonnici MR, Corradini F, Waldron T, Bender TP, Calabretta B. Requirement of c-Myb for p210BCR/ABL-dependent transformation of hematopoietic progenitors and leukemogenesis. Blood 2008, 111:4771-4779. 10.1182/blood-2007-08-105072, 2343605, 18227349.